Some IBD Patients Have Increased Skin Cancer Risk

Past research has cautioned about the risk of skin cancer with use of immunosuppressive medications. Yet, a new study pointed out, there is limited information on repeated basal cell cancer (BCC) occurrences among inflammatory bowel disease (IBD) patients, especially those who use immunosuppressive medications.

Extraordinary times

“Extraordinary times call for extraordinary measures.” — Benet Wilson

Last month’s U.S. Medicine August 2020 editorial, “It feels like writing ‘Bad things are about to happen’ on a napkin and then setting the napkin on fire.” — Colin Carlson, was angry. This month’s editorial is an admission of regret for that anger, a recognition that anger serves no useful purpose in the face of national tragedy. It perhaps defines a better way to act going forward. Admittedly, the editorial was cathartic for me. Still, I am not sure it was much of a public service to my readers. The depth and breadth of the COVID-19 pandemic in this country has been overwhelming to society. It has exposed divisions in our union that have been simmering under our national veneer of unity.

Surveillance, Barriers to Care Key to Federal Medicine Fight Against HCC

Mortality rates from most cancers have declined in recent years, but deaths from hepatocellular carcinoma continue to climb. Both the VA and the DoD are moving aggressively to detect and treat liver disease before it progresses to hepatocellular carcinoma (HCC) and to quickly identify patients who have developed this devastating disease.